Literature DB >> 31292933

The maximum possible amount of drug in rapidly separating microneedles.

Dan Dan Zhu1, Xiao Peng Zhang1, Chang Bing Shen2, Yong Cui3, Xin Dong Guo4.   

Abstract

There is an increasing concern on the drug loading capacity of microneedles (MNs) to meet higher drug dosage requirement. The present study describes the fabrication of modified rapidly separating polyvinyl alcohol (PVA)-based MNs (RS-P-MNs) with high drug loading using a mechanical agitation process. The drugs encapsulated within the PVA polymer gel by mechanical agitation served as an encapsulating agent for drugs that provide a high drug loading capacity and also release of drugs in a controlled manner. The various parameters such as microscopic analysis, atomic force microscopy (AFM), drug loading, drug delivery efficiency, mechanical test, skin penetration ability, and in vitro and in vivo analyses indicate the great potential of the RS-P-MNs. The maximum drug loading capacity of RS-P-MNs was measured to be approximately 900 ng per microneedle, which was almost a hundred times than the traditional drug encapsulating mode. The in vitro and in vivo results suggested that the controlled release of drugs is due to the encapsulating mode (mechanical agitation) of drugs. The prepared RS-P-MNs with high drug loading in this study provided a gentle and controlled release of drugs instead of the robust release of drugs from traditional MNs. Graphical abstract.

Entities:  

Keywords:  Controlled release; Microneedle; Polymers; Rapidly separating

Mesh:

Substances:

Year:  2019        PMID: 31292933     DOI: 10.1007/s13346-019-00658-7

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  27 in total

Review 1.  Microneedle technologies for (trans)dermal drug and vaccine delivery.

Authors:  Koen van der Maaden; Wim Jiskoot; Joke Bouwstra
Journal:  J Control Release       Date:  2012-02-04       Impact factor: 9.776

Review 2.  Microporation applications for enhancing drug delivery.

Authors:  Ajay K Banga
Journal:  Expert Opin Drug Deliv       Date:  2009-04       Impact factor: 6.648

3.  Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro.

Authors:  Ryan F Donnelly; Thakur Raghu Raj Singh; Michael M Tunney; Desmond I J Morrow; Paul A McCarron; Conor O'Mahony; A David Woolfson
Journal:  Pharm Res       Date:  2009-09-11       Impact factor: 4.200

4.  Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.

Authors:  H S Gill; J Söderholm; M R Prausnitz; M Sällberg
Journal:  Gene Ther       Date:  2010-03-04       Impact factor: 5.250

5.  Minimally invasive protein delivery with rapidly dissolving polymer microneedles.

Authors:  Sean P Sullivan; Niren Murthy; Mark R Prausnitz
Journal:  Adv Mater       Date:  2008-03       Impact factor: 30.849

6.  Hollow microneedles for intradermal injection fabricated by sacrificial micromolding and selective electrodeposition.

Authors:  James J Norman; Seong-O Choi; Nhien T Tong; Avishek R Aiyar; Samirkumar R Patel; Mark R Prausnitz; Mark G Allen
Journal:  Biomed Microdevices       Date:  2013-04       Impact factor: 2.838

7.  A fabrication method of microneedle molds with controlled microstructures.

Authors:  Qi Lei Wang; Dan Dan Zhu; Yang Chen; Xin Dong Guo
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-04-13       Impact factor: 7.328

8.  Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.

Authors:  Ming-Hung Ling; Mei-Chin Chen
Journal:  Acta Biomater       Date:  2013-06-29       Impact factor: 8.947

9.  Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.

Authors:  James J Norman; Milton R Brown; Nicholas A Raviele; Mark R Prausnitz; Eric I Felner
Journal:  Pediatr Diabetes       Date:  2013-03-21       Impact factor: 4.866

10.  Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.

Authors:  Maelíosa T C McCrudden; Ahlam Zaid Alkilani; Cian M McCrudden; Emma McAlister; Helen O McCarthy; A David Woolfson; Ryan F Donnelly
Journal:  J Control Release       Date:  2014-02-17       Impact factor: 9.776

View more
  1 in total

Review 1.  Design and development of insulin microneedles for diabetes treatment.

Authors:  Qida Zong; Ranran Guo; Naijun Dong; Guixia Ling; Peng Zhang
Journal:  Drug Deliv Transl Res       Date:  2021-04-13       Impact factor: 4.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.